Preparing for a post-antibiotic world
Antibiotics still save millions of lives. However, their power is fading. As resistance grows, today’s infection care standards will no longer be enough. Healthcare systems must start planning now.
Current treatment guidelines focus heavily on antibiotics. For example, the US military wound care rules rarely recommend topical antiseptics. The only routine exception involves burn wounds, where damaged tissue limits antibiotic delivery. This raises a serious question. What happens when antibiotics stop working?
The growing threat of antimicrobial resistance
Antimicrobial resistance continues to rise worldwide. The World Health Organization reported in 2025 that one in six confirmed bacterial infections no longer responds to antibiotics. That figure has risen sharply in just five years.
The situation looks even worse in conflict zones. In Ukraine, most injured patients arrive days after injury. Many already carry multi-drug resistant infections. A large share of these infections resist every available antibiotic.
Because of this trend, care guidelines must change. Waiting will only increase risk.
Resistance on the battlefield
War zones create ideal conditions for resistance. Hygiene breaks down. Supplies run low. Antibiotic control becomes nearly impossible.
This leads to another key question. Do patients pick up resistant bacteria in combat zones or inside hospitals?
Past conflicts offer clues. During the Iraq war, a resistant strain of Acinetobacter caused death rates as high as seventy percent. Later studies showed that field hospitals and care facilities played a major role in spreading these infections.
Resistant bacteria often lose their strength in nature. However, antibiotics remove their competition. Hospitals, where antibiotics are common, give resistant strains space to thrive.
Hospitals are a major risk area
Healthcare settings already struggle with infection control. Each year, hospital-acquired infections affect more than one hundred million people worldwide. Millions die as a result.
In developing regions, infection rates can reach one quarter of patients. Even in wealthier countries, rates remain high. Resistance threatens to undo years of progress in infection reduction.
This does not mean hospitals are unsafe. Many have improved. Still, rising resistance puts those gains at risk.
Where can prevention improve the most
Hospitals must focus on two areas. First, reducing places where pathogens live. Second, stopping their spread.
High-touch surfaces receive the most attention. However, outbreaks still occur. Candida auris offers a clear example. This fungus spreads fast, resists cleaning, and causes high death rates. It survives where other microbes die and spreads easily through shared equipment.
Small tools often escape routine disinfection. Over time, they fuel outbreaks that last for years.
Hand hygiene still falls short.
Hand hygiene remains another weak point. Many hospital infections trace back to poor hand cleaning. Yet compliance averages only about sixty percent.
As resistance rises, even small lapses matter more. Each missed hand wash increases the risk of spreading dangerous organisms.
Both surfaces and hands need protection that lasts longer than a few minutes.
The overlooked reservoir: patient skin
One surface gets little attention. Patient skin.
Skin is not cleaned daily like rooms or equipment. Antibiotics also change the skin’s balance. They remove harmless bacteria and allow resistant ones to take over.
Targeted efforts against single organisms have shown limited success. In contrast, broad decolonisation has reduced resistant organisms by more than twenty percent. It has also lowered infection-related hospital transfers.
So why do hospitals hesitate? Time and cost. Staff already feel stretched. Short-acting products add work without lasting benefit.
The need for long-lasting protection
Long-lasting antiseptics could change this balance. Residual protection would lower contamination, reduce infection spread, and cut the need for strict isolation.
This would also save staff time. In turn, that time could support wider decolonisation efforts with better results.
Current disinfectants fall short. Bleach and similar agents clean well but leave no lasting protection. Some also damage surfaces or skin. Others show limited coverage or growing resistance.
Limits of today’s antiseptics
Available skin antiseptics also have problems. Some irritate the skin with repeated use. Others cannot cover the full body safely. Alcohol dries skin and weakens its barrier.
None offers strong long-term protection without trade-offs.
A new approach with AVA 003
AvantGuard has developed a new antiseptic compound called AVA 003. It aims to meet the demands of a post-antibiotic world.
AVA 003 uses chlorine chemistry, similar to how the immune system fights pathogens. It delivers broad protection against bacteria, fungi, spores, and viruses. At the same time, it stays safe for skin, wounds, and surfaces.
Unlike antibiotics, it remains effective even at low doses. It also provides residual protection, much like treated water or pools.
This makes AVA 003 suitable for hands, skin, and hospital surfaces without corrosion or irritation.
Looking ahead
The post-antibiotic era is approaching fast. Infection prevention must adapt.
Future care will depend less on antibiotics alone and more on smart prevention. Long-lasting antiseptics may play a central role.
Innovation like AVA 003 shows one possible path forward. Without change, resistance will continue to outpace medicine.
